Additionally, atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are early markers of cardiac diastolic dysfunction, reflecting changes in atrioventricular pressure, and can be used for the early screening and prognosis of DCM [104]. The gene discussed is NPPB; the disease is familial dilated cardiomyopathy.